Ivana Carey

Denmark Hill
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review.

Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review.

Journal: Journal of viral hepatitis

Published: June 08, 2026

Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection.

Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection.

Journal: JHEP reports : innovation in hepatology

Published: March 11, 2026

Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).

Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).

Journal: Hepatology (Baltimore, Md.)

Published: September 19, 2025

Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia.

Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia.

Journal: Gut

Published: July 04, 2025

Comment on "Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta".

Comment on "Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta".

Journal: Journal of hepatology

Published: April 17, 2025

Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.

Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Alimentary pharmacology & therapeutics

Published: April 10, 2025

Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC.

Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC.

Journal: Journal of viral hepatitis

Published: March 22, 2025

Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa.

Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa.

Journal: The Journal of infection

Published: March 04, 2025

Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme.

Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme.

Journal: Virology

Published: November 28, 2024

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Journal: Journal of hepatology

Published: July 20, 2024

Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.

Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 13, 2024

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Journal: Clinical therapeutics

Published: September 13, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026